D. Al-Numani

Influence of Different Populations on Pharmacokinetic Bioequivalence Results: Can We Extrapolate Bioequivalence Results from One Population to Another?

A. Fuglsang, M. Ducharme, F. Varin, 2020, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Rethinking bioequivalence and equivalence requirements of orally inhaled drug products

M. Ducharme, P. Colucci, D. Al-Numani, 2015 .

Proinflammatory cytokine and chemokine modulation by Streptococcus suis in a whole-blood culture system.

M. Olivier, M. Gottschalk, M. Segura, 2006, FEMS immunology and medical microbiology.

Pro-inflammatory cytokine and chemokine release by human brain microvascular endothelial cells stimulated by Streptococcus suis serotype 2.

M. Gottschalk, M. Segura, G. Vanier, 2003, FEMS immunology and medical microbiology.

Up‐regulation of ICAM‐1, CD11a/CD18 and CD11c/CD18 on human THP‐1 monocytes stimulated by Streptococcus suis serotype 2

M. Gottschalk, M. Segura, M. Doré, 2003, Clinical and experimental immunology.

Comparative bioavailability of a generic capsule formulation of the reverse transcriptase inhibitor efavirenz and the innovator product.

J. Marier, T. Monif, A. Singla, 2006, International journal of clinical pharmacology and therapeutics.